Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
EMBO J
1987 May 01;65:1219-24. doi: 10.1002/j.1460-2075.1987.tb02357.x.
Show Gene links
Show Anatomy links
B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF).
Poupart P
,
Vandenabeele P
,
Cayphas S
,
Van Snick J
,
Haegeman G
,
Kruys V
,
Fiers W
,
Content J
.
???displayArticle.abstract???
The human "26-kd protein' is a secreted glycoprotein expressed, for example, in (blood) leukocytes, in epithelial cells treated with various inducers, but most strongly in interleukin-1 (IL-1)-treated fibroblasts. After finding it has antiviral and 2-5A synthetase-inducing activity, one group of authors called this protein IFN-beta 2. However, recently the full-length 26-kd cDNA sequence was shown to be identical with that of a B-cell-differentiating lymphokine called BSF-2, and another report suggested that the 26-kd protein could support the growth of some transformed murine B cell lines. To define its biological activities, we expressed the recombinant 26-kd protein by translating in Xenopus laevis oocytes a pure, synthetic chimeric mRNA containing the 26-kd protein coding region surrounded by Xenopus laevis beta-globin untranslated regions. A similar construction, but containing the HuIFN-beta cDNA coding region, was used to produce HuIFN-beta by the same procedure. Both recombinant glycoproteins were secreted, glycosylated, and their amounts were measured by [35S]methionine incorporation by the oocyte. Here we show that the recombinant 26-kd protein exhibits a high growth factor activity when assayed on an IL-HP1-dependent murine B cell hybridoma (sp. act. approximately 2 X 10(8) U/mg) as well as a potent differentiating activity on human CESS cells (sp. act. approximately 5 X 10(7) U/mg). While rHuIFN-beta was inactive in the latter two assays, it had the expected antiviral activity of 1-5 X 10(8) U/mg. The parallel recombinant 26-kd protein preparations had no detectable antiviral activity (i.e. a maximal specific activity of 1-3 X 10(2) U/mg, if any). The 26-kd protein is thus clearly an interleukin, and considering the confusing nomenclature now in use, this factor may better be renamed "interleukin 6'.
Chebath,
Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA.
1983, Pubmed
Chebath,
Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA.
1983,
Pubmed
Content,
Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta.
1982,
Pubmed
,
Xenbase
Content,
Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1-related, leukocyte-derived factor.
1985,
Pubmed
Contreras,
Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes.
1982,
Pubmed
,
Xenbase
Derynck,
Expression of human fibroblast interferon gene in Escherichia coli.
1980,
Pubmed
Gurdon,
Changes in somatic cell nuclei inserted into growing and maturing amphibian oocytes.
1968,
Pubmed
,
Xenbase
Haegeman,
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts.
1986,
Pubmed
Hirano,
Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).
1985,
Pubmed
Hirano,
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin.
,
Pubmed
Knight,
Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence.
1980,
Pubmed
Kohase,
Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.
1986,
Pubmed
Krieg,
Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.
1984,
Pubmed
,
Xenbase
Landegren,
Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens.
1984,
Pubmed
Pelham,
An efficient mRNA-dependent translation system from reticulocyte lysates.
1976,
Pubmed
Poupart,
Induction and regulation of the 26-kDa protein in the absence of synthesis of beta-interferon mRNA in human cells.
1984,
Pubmed
Rinderknecht,
Natural human interferon-gamma. Complete amino acid sequence and determination of sites of glycosylation.
1984,
Pubmed
Roberts,
Type beta transforming growth factor: a bifunctional regulator of cellular growth.
1985,
Pubmed
Van Snick,
Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.
1987,
Pubmed
Van Snick,
Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
1986,
Pubmed
Vaquero,
Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes.
1986,
Pubmed
Wathelet,
Molecular cloning, full-length sequence and preliminary characterization of a 56-kDa protein induced by human interferons.
1986,
Pubmed
,
Xenbase
Weissenbach,
Identification of the translation products of human fibroblast interferon mRNA in reticulocyte lysates.
1979,
Pubmed
Weissenbach,
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies.
1980,
Pubmed
White,
Cytoplasmic dot hybridization. Simple analysis of relative mRNA levels in multiple small cell or tissue samples.
1982,
Pubmed
Zilberstein,
Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines.
1986,
Pubmed